News
Genomed enters NewConnect
January 20, 2011
Genomed S.A. is planning its debut in NewConnect market in the first half of 2011. The Company renders services in the area of sequencing, DNA analysis and synthesis for over 200 scientific centres, biotechnological companies and medical institutions.
Genomed S.A. is planning its debut in NewConnect market in the first half of 2011. The Company renders services in the area of sequencing, DNA analysis and synthesis for over 200 scientific centres, biotechnological companies and medical institutions. The company's activity is oriented at implementation of modern technology in the area of personalised medicine based on DNA sequencing and diagnostics of genetic diseases. Under a private offering the company intends to obtain PLN 5 million which will be allocated for investments in development and further expansion.
